SI-BONE Investor Relations Material

SI-BONE Inc. is a medical technology company that develops and markets minimally invasive surgical solutions for the treatment of sacroiliac (SI) joint disorders. The company's primary product, iFuse Implant System, is designed to treat conditions such as sacroiliac joint dysfunction and sacroiliitis by providing stabilization and fusion of the SI joint. SI-BONE’s solutions aim to improve patient outcomes and reduce pain for individuals with lower back conditions linked to the SI joint. The company is headquartered in Santa Clara, California, and its shares are listed on the NASDAQ.